Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record.

DEVELOPMENT OF ELISA-DETECTED ANTI-HLA ANTIBODIES PRECEDES THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AND CORRELATES WITH PROGRESSIVE DECLINE IN PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION1

Jaramillo, Andr??s, Smith, Michael A., Phelan, Donna, Sundaresan, Sudhir, Trulock, Elbert P., Lynch, John P., Cooper, Joel D., Patterson, G. Alexander, Mohanakumar, T.·1999·Transplantation

Abstract

BACKGROUND: Development of anti-HLA antibodies after lung transplantation (LT) is thought to play an important role in the etiology of bronchiolitis obliterans syndrome (BOS). However, a cause-effect relationship between anti-HLA antibodies and BOS has not been established. This study was conducted to determine the temporal relationship between the development of anti-HLA antibodies and BOS after LT, and to determine the antigenic specificity of the antibodies developed in BOS patients. METHODS: Sera from 15 BOS+ LT patients and 12 BOS- LT patients were obtained before LT and collected again at 6, 12, 24, 36, and 48 months after LT. Anti-HLA antibodies were detected by the PRA-STAT ELISA system and by complement-dependent cytotoxicity assays. Anti-HLA reactivity was further characterized by flow cytometry and absorption/elution with human platelets. RESULTS: When analyzed by ELISA, 10 of 15 BOS+ patients developed anti-HLA antibodies, whereas 0 of 12 BOS- patients developed anti-HLA antibodies (P<0.001). When analyzed by complement-dependent cytotoxicity, only 2 of 15 BOS+ patients developed anti-HLA antibodies and 1 of 12 BOS- patients developed anti-HLA antibodies (P = 0.99). There was a significant difference of 20.1 months between the time of anti-HLA antibody detection and the time of BOS diagnosis (P = 0.005). A progressive decrease in pulmonary function correlated with a progressive increase in the anti-HLA reactivity 36 months after LT. The anti-HLA reactivity was directed to one of the donor HLA class I antigens and to other unrelated HLA class I antigens. No anti-HLA reactivity was found against HLA class II molecules. CONCLUSIONS: Our study indicates that anti-HLA class I antibodies play an important role in the pathogenesis of BOS and that monitoring of anti-HLA class I antibody development by a highly sensitive assay such as the PRA-STAT ELISA after LT can provide an early identification of an important subset of LT patients with an increased risk of developing BOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00007890-199904270-00012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 194

Metadata

Authors
Jaramillo, A., Smith, M. A., Phelan, D., Sundaresan, S., Trulock, E. P., Lynch, J. P., Cooper, J. D., Patterson, G. A., & Mohanakumar, T.
Venue
Transplantation
Published
1999-04
Volume
67
Issue
8
Pages
1155-1161
ISSN
0041-1337 (ISSN-L)
OpenAlex
W2112408403
Cited by
194
References
0
FWCI
9.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DEVELOPMENT OF ELISA-DETECTED ANTI-HLA ANTIBODIES PRECEDES THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AND CORRELATES WITH PROGRESSIVE DECLINE IN PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION1. https://app.cochat.ai/papers/10.1097/00007890-199904270-00012
The paper
Jaramillo, A., Smith, M. A., Phelan, D., Sundaresan, S., Trulock, E. P., Lynch, J. P., Cooper, J. D., Patterson, G. A., & Mohanakumar, T. (1999). DEVELOPMENT OF ELISA-DETECTED ANTI-HLA ANTIBODIES PRECEDES THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AND CORRELATES WITH PROGRESSIVE DECLINE IN PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION1. Transplantation. https://doi.org/10.1097/00007890-199904270-00012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.